COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Pyrum Innovations AG resolves cash capital increase from authorised capital with exclusion of subscription rights
Pyrum Innovations AG resolves cash capital increase from authorised capital with exclusion of subscription rights. New shares offered at EUR 27.50. Proceeds for new site, joint ventures, and corporate purposes -
COMMUNIQUÉ RÉGLEMENTÉ
Déclaration hebdomadaire d'opérations effectuées du 14 au 18 octobre 2024
-
COMMUNIQUÉ RÉGLEMENTÉ
Disclosure of transactions in own shares on October 14 to October 18, 2024
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: STEICO SE: STEICO SE: Business figures for the first nine months of the 2024 financial year; adjustment of the annual guidance for 2024
STEICO SE announces business figures for the first nine months of 2024 with adjustment in annual guidance, citing increased revenue and EBIT -
-
COMMUNIQUÉ DE PRESSE
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
Prolocor, Inc. announces publication of results from a confirmatory 800 patient ACS trial in JACC, showing a >2-fold predictive value for heart attack, stroke, and death. The Prolocor pFCG® test supports individualized antiplatelet therapy -
